Newest
BETR ▼ sold $13K · Tuffin Paula filed 2d agoBETR ▼ sold $14K · Nicholas J. Calamari filed 2d agoFBK ▲ bought $716K · INGRAM ORRIN H II filed 2d agoFBK ▲ bought $821K · INGRAM ORRIN H II filed 2d agoBEN ▼ sold $5.0M · FRANKLIN TEMPLETON INC filed 2d agoNAD ▼ sold $338K · Robert Young L filed 3d agoWSBC ▼ sold $15K · Rep. Michael A. Rulli filed 4d agoGOOG ▼ sold $100K · Rep. Michael A. Rulli filed 4d agoWMT ▼ sold $100K · Rep. Jonathan L. Jackson filed 4d agoVSAT ▼ sold $100K · Rep. Jonathan L. Jackson filed 4d agoTYG ▼ sold $15K · Rep. Jonathan L. Jackson filed 4d agoGH ▲ bought $50K · Rep. Jonathan L. Jackson filed 4d agoEL ▲ bought $100K · Rep. Jonathan L. Jackson filed 4d agoDDOG ▲ bought $100K · Rep. Jonathan L. Jackson filed 4d agoCPRT ▼ sold $553K · Morefield Diane M filed 4d agoPTON ▼ sold $154K · Kirol Charles Peter filed 4d agoEME ▲ bought $1K · MCEVOY M KEVIN filed 4d agoEME ▲ bought $826 · MCEVOY M KEVIN filed 4d ago

Insider / AMGEN INC

Bradway Robert A

Chairman, CEO and President at AMGEN INC

Company
AMGEN INC
Tickers
BA, AMGN
First filing on record
October 3, 2025
Latest trade on record
July 1, 2026
SEC filings
EDGAR ↗

Bradway Robert A, Chairman, CEO and President at AMGEN INC, has disclosed 15 transactions in BA, AMGN since October 3, 2025: 0 purchases (0 open-market buys) and 6 sales, worth about $87.5M at the reported prices. The latest was filed July 6, 2026, 5 days after the trade; 1 filing was late against the 2-business-day Form 4 deadline.

Last updated July 6, 2026 · Source: SEC EDGAR Form 4 filings

Transactions
15
Open-market buys
0
Sales
6
Avg. disclosure lag
2.5d

Trading in charts

Trade timeline

When does this person trade, how big, and in which direction? Every trade in the last 12 months.

Bought (above the line)Sold (below the line)Other transaction
Oct 25NovDecJan 26FebMarAprMayJunJulAugSep
Oct 25NovDecJan 26FebMarAprMayJunJulAugSep

In the last 12 months Bradway Robert A made no purchases and 6 sales worth $43M, plus 8 other transactions. Dot size is the dollar amount.

Portfolio mix

Which stocks does this person trade most? Tile size is dollars traded, all time on record.

AMGN$42.7M
AMGN$42.7M

Bradway Robert A has traded 1 stock on record; the largest by dollars is AMGN.

Reporting lag

Does this person report on time? One bar per filing against the Form 4 deadline.

On timeLate
Form 4 deadlineoldest filingnewest

1 of 10 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).

What kind of transactions

Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.

Rows by Form 4 transaction code
CodeMeaningRowsSharesValue
AGrant or award7135,616$26.1M
FShares withheld for tax6114,417$42.7M
MOption exercise or conversion2239,564$18.7M
Rows by year of the trade
YearRowsBoughtSold
20261406 · $42.7M
2025100

Transactions

Download AMGN trades (CSV)165 rows · 53 KB · every filer in this ticker, this insider included · all downloads

SecuritySideTrade dateDisclosedLagSharesPriceValueFlagsSourceShare
BAOther AJuly 1, 2026July 6, 20265d406——latederivativeForm 4 ↗
AMGNSell FMay 7, 2026May 11, 20264d2,079$331$688KForm 4 ↗
AMGNOther AMay 5, 2026May 7, 20262d79,176$330$26.1MderivativeForm 4 ↗
AMGNSell FMay 6, 2026May 7, 20261d1,702$330$561KForm 4 ↗
AMGNOther AMay 5, 2026May 7, 20262d12,136——Form 4 ↗
AMGNSell FMay 2, 2026May 5, 20263d2,426$330$800KForm 4 ↗
AMGNSell FMay 2, 2026May 5, 20263d2,631$330$868KForm 4 ↗
BAOther AApril 1, 2026April 3, 20262d428——derivativeForm 4 ↗
AMGNSell FMarch 16, 2026March 18, 20262d21,294$366$7.8MForm 4 ↗
AMGNOption / conversion MMarch 4, 2026March 6, 20262d119,782——derivativeForm 4 ↗
AMGNSell FMarch 4, 2026March 6, 20262d84,285$379$32.0MForm 4 ↗
AMGNOption / conversion MMarch 4, 2026March 6, 20262d119,782$156$18.7MForm 4 ↗
AMGNOther AMarch 3, 2026March 5, 20262d42,657——Form 4 ↗
BAOther AJanuary 2, 2026January 6, 20264d400——derivativeForm 4 ↗
BAOther AOctober 1, 2025October 3, 20252d413——derivativeForm 4 ↗

Filings

FiledFormAccessionRowsStatusSource
July 6, 2026Form 40001225208-26-0065041publishedEDGAR ↗
May 11, 2026Form 40000318154-26-0000841publishedEDGAR ↗
May 7, 2026Form 40000318154-26-0000813publishedEDGAR ↗
May 5, 2026Form 40000318154-26-0000582publishedEDGAR ↗
April 3, 2026Form 40001225208-26-0043761publishedEDGAR ↗
March 18, 2026Form 40000318154-26-0000251publishedEDGAR ↗
March 6, 2026Form 40000318154-26-0000233publishedEDGAR ↗
March 5, 2026Form 40000318154-26-0000141publishedEDGAR ↗
January 6, 2026Form 40001225208-26-0004261publishedEDGAR ↗
October 3, 2025Form 40001225208-25-0084991publishedEDGAR ↗

Other insiders at AMGEN INC

Everyone on file, with contracts and lobbying under the company's name: AMGEN INC.

Guides for this page

Sources and method

Official sources behind this page
SourceFilingsRowsFirst filedNewest filedRead the originals
SEC EDGAR, Form 41015October 3, 2025July 6, 2026Form 4 list on EDGAR

Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.

Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.

Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.